DSM-Firmenich, CH1216478797

DSM-Firmenich Stock - Thursday chart check after recent consolidation

18.06.2026 - 18:58:56 | ad-hoc-news.de

DSM-Firmenich stock has traded sideways in recent weeks after the 2025 results and dividend. This Thursday, the focus shifts to the chart: where the shares sit versus recent highs, how liquidity looks on SIX, and what that means for volatility.

DSM-Firmenich, CH1216478797
DSM-Firmenich, CH1216478797

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:57 CET. Details in the imprint.

DSM-Firmenich (CH1216478797) remains a mid-to-large Swiss chemicals and nutrition name on the SIX exchange. With no fresh corporate announcements on Thursday, the focus shifts to where the chart stands after recent consolidation in the shares.

Go deeper

All news and background on DSM-Firmenich stock

Further company announcements, price data and regulatory filings on DSM-Firmenich can be found in the dedicated topic channel and on the group’s investor-relations page.

How the chart is positioned

DSM-Firmenich shares have been trading in a relatively narrow range on SIX in recent weeks, following the publication of the 2025 full-year figures and dividend proposal earlier this year. The stock remains below its post-merger highs but above the lows seen during 2024’s market volatility.

Turnover has been moderate, consistent with a stock that sits firmly in institutional portfolios rather than being a high-frequency trading favorite. Day-to-day volatility has been muted, with no sudden gaps driven by company-specific headlines this week.

Key technical reference points

On Thursday, DSM-Firmenich shares continued to move sideways around recent levels, without testing major support or resistance zones on strong volume. The price action reflects a market that is waiting for the next fundamental trigger such as updated guidance or a major portfolio move.

Against a broader European chemicals and specialty ingredients backdrop, the stock performance has been broadly in line with peers in 2025 and into 2026, according to regional sector overviews. That suggests no clear technical divergence, but also no sign of strong momentum emerging yet.

What the company sells

DSM-Firmenich generates most of its revenue from nutrition, health and beauty ingredients, along with flavors and fragrances used in food, beverages and consumer products, as outlined on the group’s corporate website. The portfolio combines DSM’s nutrition strengths with Firmenich’s fragrance expertise.

Where the stock trades today

DSM-Firmenich (CH1216478797) shares trade on SIX Swiss Exchange in Zurich; the latest available price data indicate a quotation in Swiss francs (CHF) on that venue.

Key facts on DSM-Firmenich stock

  • Company: dsm-firmenich AG
  • ISIN: CH1216478797
  • Venue: SIX Swiss Exchange
  • Sector / Industry: Materials - Specialty chemicals, flavors and fragrances

More on DSM-Firmenich stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | CH1216478797 | DSM-FIRMENICH | boerse | 69574971 | bgmi